+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Lamivudine"

HIV Drugs Market Report 2025 - Product Thumbnail Image

HIV Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Hepatitis Drugs Market Report 2025 - Product Thumbnail Image

Hepatitis Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
Entecavir Market Size, Forecast, and Market Insight - 2032 - Product Thumbnail Image

Entecavir Market Size, Forecast, and Market Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
From
Antiviral Drugs Market Report and Forecast 2023-2031 - Product Thumbnail Image

Antiviral Drugs Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
From
HIV Drugs Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

HIV Drugs Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Pregnancy and Anti-Infective Agents - Product Thumbnail Image

Pregnancy and Anti-Infective Agents

  • Book
  • November 2020
From
  • 14 Results (Page 1 of 1)
Loading Indicator

Lamivudine is an antiviral medication used to treat immune disorders such as HIV and hepatitis B. It is a nucleoside reverse transcriptase inhibitor (NRTI) that works by blocking the action of the virus’s reverse transcriptase enzyme, which is responsible for the replication of the virus. Lamivudine is used in combination with other drugs to treat HIV and hepatitis B infections. It is also used to prevent mother-to-child transmission of HIV. Lamivudine is available in both generic and brand-name formulations. It is available in tablet, capsule, and oral solution forms. The drug is available in various strengths and is usually taken once or twice daily. The market for lamivudine is highly competitive, with many companies offering generic and brand-name formulations. Some of the companies in the market include Mylan, Teva Pharmaceuticals, Cipla, and Sun Pharmaceuticals. Show Less Read more